查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722864

2025 年至 2033 年經皮貼片市場規模、佔有率、趨勢及預測（按類型、配銷通路、應用及地區）

Transdermal Skin Patches Market Size, Share, Trends and Forecast by Type, Distribution Channel, Application, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球經皮貼片市場規模價值 82.1 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 115.6 億美元，2025-2033 年期間的複合年成長率為 3.69%。北美目前佔據市場主導地位，到 2024 年將佔據 35.5% 的顯著市場。由於先進的醫療保健基礎設施支持創新的經皮技術，市場正在經歷成長。慢性病的高發生率確保了對有效、非侵入性治療方案的持續需求。除此之外，強大的製藥公司影響力和良好的監管框架推動了產品開發和法規核准，鞏固了該地區在全球經皮貼片市場佔有率中的重要性。

經皮貼片是一種非侵入性且易於使用的藥物傳遞方法，可在預定時間內將恆定且一致的治療劑量輸送到血液中。它們由背襯、藥物、薄膜、黏合劑、襯墊、化學增強劑和滲透劑、物理輔助劑和離子電滲療法等低電流組成。根據皮膚的特性和貼片的設計，它們提供一致的擴散率。如今，它們在世界各地被廣泛用作化妝品、外用藥和經皮給藥系統。

經皮貼片市場趨勢：

經皮貼片可有效治療心臟和內分泌失調、偏頭痛、帕金森氏症、阿茲海默症、中風、人類免疫缺陷病毒 (HIV)、骨質疏鬆症和不安腿症候群。因此，患有這些疾病的人口比例顯著增加是推動市場成長的關鍵因素之一。此外，這些貼片有助於避免傳統的口服藥物途徑，減少靜脈或腸外治療的不便，並防止胃腸道毒性、噁心和嘔吐。此外，由於使用方便，經皮貼片越來越受到人們的青睞，可以提高患者在長期治療慢性疼痛和戒菸治療中的依從性。除此之外，對價格實惠、療效更好的治療方法的需求不斷增加，加上不同類別藥物臨床試驗數量的顯著增加，對市場產生了積極影響。此外，壓敏膠合劑和滲透促進劑的引入，可增加產品擴散並增強藥物保留能力，預計將為市場參與者提供有利可圖的機會，並在未來幾年擴大經皮貼片在全球範圍內的應用。

本報告回答的關鍵問題

  • 經皮貼片市場有多大？經皮貼片市場的未來前景如何？
  • 推動經皮貼片市場發展的關鍵因素有哪些？
  • 哪個地區佔據了經皮貼片最大的市場佔有率？
  • 全球經皮貼片市場領先的公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球經皮貼片市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 單層藥物黏合劑
  • 多層藥物黏合劑
  • 矩陣
  • 其他

第7章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路商店

第 8 章：市場區隔：按應用

  • 緩解疼痛
  • 減少和戒菸援助
  • 膀胱過動症
  • 荷爾蒙療法
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3M Company
    • AdhexPharma
    • LTS Lohmann Therapie-Systeme AG
    • Luye Pharma Group
    • Medherant Limited
    • Nitto Denko Corporation
    • Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
    • Prosolus Inc.
    • Samyang Holdings Corporation
    • Tapemark
    • Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
    • tesa SE (Beiersdorf AG)
    • Teva Pharmaceutical Industries Ltd
Product Code: SR112025A5142

The global transdermal skin patches market size was valued at USD 8.21 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 11.56 Billion by 2033, exhibiting a CAGR of 3.69% during 2025-2033. North America currently dominates the market, holding a significant market share of 35.5% in 2024. The market is experiencing growth because of advanced healthcare infrastructure supporting innovative transdermal technologies. High prevalence of chronic conditions ensures sustained demand for effective, non-invasive treatment options. Besides this, strong presence of pharmaceutical companies and favorable regulatory frameworks drive product development and regulatory approvals, solidifying the region's significance in the global transdermal skin patches market share.

Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.

Transdermal Skin Patches Market Trends:

Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.

Key Market Segmentation:

Breakup by Type:

  • Single-layer Drug-in-Adhesive
  • Multi-layer Drug-in-Adhesive
  • Matrix
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

Breakup by Application:

  • Pain Relief
  • Smoking Reduction and Cessation Aid
  • Overactive Bladder
  • Hormonal Therapy
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1.How big is the transdermal skin patches market?
  • 2.What is the future outlook of transdermal skin patches market?
  • 3.What are the key factors driving the transdermal skin patches market?
  • 4.Which region accounts for the largest transdermal skin patches market share?
  • 5.Which are the leading companies in the global transdermal skin patches market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Skin Patches Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single-layer Drug-in-Adhesive
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Multi-layer Drug-in-Adhesive
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Stores
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Relief
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Smoking Reduction and Cessation Aid
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Overactive Bladder
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Hormonal Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AdhexPharma
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 LTS Lohmann Therapie-Systeme AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Luye Pharma Group
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Medherant Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Nitto Denko Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Prosolus Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Samyang Holdings Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Tapemark
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 tesa SE (Beiersdorf AG)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Teva Pharmaceutical Industries Ltd
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Transdermal Skin Patches Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Skin Patches Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Transdermal Skin Patches Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Transdermal Skin Patches Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Transdermal Skin Patches Market: Breakup by Distribution Channel (in %), 2024
  • Figure 6: Global: Transdermal Skin Patches Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Transdermal Skin Patches Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Transdermal Skin Patches (Matrix) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Transdermal Skin Patches (Matrix) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Transdermal Skin Patches (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Transdermal Skin Patches (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Transdermal Skin Patches (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Transdermal Skin Patches (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Transdermal Skin Patches (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Transdermal Skin Patches (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Transdermal Skin Patches (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Transdermal Skin Patches (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Transdermal Skin Patches (Pain Relief) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Transdermal Skin Patches (Pain Relief) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Transdermal Skin Patches (Overactive Bladder) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Transdermal Skin Patches (Overactive Bladder) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Transdermal Skin Patches (Hormonal Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Transdermal Skin Patches (Hormonal Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Transdermal Skin Patches (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Transdermal Skin Patches (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Transdermal Skin Patches Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Transdermal Skin Patches Industry: SWOT Analysis
  • Figure 82: Global: Transdermal Skin Patches Industry: Value Chain Analysis
  • Figure 83: Global: Transdermal Skin Patches Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Skin Patches Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Transdermal Skin Patches Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Transdermal Skin Patches Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 4: Global: Transdermal Skin Patches Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Transdermal Skin Patches Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Transdermal Skin Patches Market: Competitive Structure
  • Table 7: Global: Transdermal Skin Patches Market: Key Players